The Association of Serum Lipid Levels with Breast Cancer Risks Among Women with Breast Cancer at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia

Breast cancer is a malignant condition affecting about 2.1 million women worldwide. Cancer cells have increased the level of cholesterol and facilitate lipid biosynthesis and metabolism. Therefore, there is a need for assessment of serum lipid and its association with breast cancer risks. A comparat...

Full description

Saved in:
Bibliographic Details
Published in:Breast cancer targets and therapy 2020-01, Vol.12, p.279-287
Main Authors: Kumie, Getinet, Melak, Tadele, Wondifraw Baynes, Habtamu
Format: Article
Language:English
Subjects:
Age
Alcohol use
Benign
Blood pressure
Breast cancer
Breastfeeding & lactation
Cancer
Cancer therapies
Cholesterol
Colorimetry
Comparative analysis
Drinking behavior
Dyslipidemia
Enzymes
ethiopia
Family medical history
Health care
High density lipoprotein
Hypertension
Lipid metabolism
lipid profile
Lipids
Lipoproteins
Low density lipoprotein
Low density lipoproteins
Menstruation
Metabolic disorders
Oncology, Experimental
Original Research
Patients
Physiological aspects
Risk factors
Sociodemographics
Statistical analysis
Tumor necrosis factor-TNF
women
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c576t-98ffe2ae58242b41940aa9daf149dd23058184f1de399b23f85a97f384019633
cites cdi_FETCH-LOGICAL-c576t-98ffe2ae58242b41940aa9daf149dd23058184f1de399b23f85a97f384019633
container_end_page 287
container_issue
container_start_page 279
container_title Breast cancer targets and therapy
container_volume 12
creator Kumie, Getinet
Melak, Tadele
Wondifraw Baynes, Habtamu
description Breast cancer is a malignant condition affecting about 2.1 million women worldwide. Cancer cells have increased the level of cholesterol and facilitate lipid biosynthesis and metabolism. Therefore, there is a need for assessment of serum lipid and its association with breast cancer risks. A comparative cross-sectional study was conducted among women with breast cancer (n=23), benign breast lump (n=68) and apparently healthy control (n=91) at Felege Hiwot Comprehensive Specialized Hospital, from January to May, 2020. A convenient sampling technique and an interviewer-administered questionnaires were used to collect data. Five milliliter of fasting blood sample was collected for lipid level analysis using enzymatic colorimetric method. Data entry and analysis were done using Epi Info version 7 and SPSS version 20. One way ANOVA and logistic regression were the tools used for analysis, and a p-value of
doi_str_mv 10.2147/BCTT.S279291
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7f359cb63a054d6fbeb0be9be91087b4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A648558602</galeid><doaj_id>oai_doaj_org_article_7f359cb63a054d6fbeb0be9be91087b4</doaj_id><sourcerecordid>A648558602</sourcerecordid><originalsourceid>FETCH-LOGICAL-c576t-98ffe2ae58242b41940aa9daf149dd23058184f1de399b23f85a97f384019633</originalsourceid><addsrcrecordid>eNptktFq2zAUhs3YWEvXu10PwWDsoskkS7asm0Ea2qUQNlgCuxSyfRQrsy1PshO259mDTl6ykoxKAomj7_wHHf1R9JrgaUwY_3A7X6-nq5iLWJBn0SUhXEwIJez5yfkiuvZ-i8fBMWP8ZXRBKU0pw_wy-r2uAM28t4VRvbEtshqtwA0NWprOlGgJO6g92pu-QrcOlO_RXLUFOPTV-O8ezRrbbtA320D7FKR6dA81bAAtzN6GsG06BxW03uwArToIZWvzC0q0sL4zvapv0Gfr-moPQeSur4ztjHoVvdCq9nB93K-i9f3der6YLL98epjPlpMi4Wk_EZnWECtIspjFOSOCYaVEqTRhoixjipOMZEyTEqgQeUx1lijBNc0YJiKl9Cp6OMiWVm1l50yj3E9plZF_A9ZtpHK9KWqQISsRRZ5ShRNWpjqHHOcgwiI44zkLWh8PWt2QN1AW0PZO1Wei5zetqeTG7iTnCc1EEgTeHwWc_TGEbsjG-ALqWrVgBy9jxsMPppinAX37H7q1g2tDp0YKJ4SKU2qjwgNMq22oW4yicpayLEmyFMeBmj5BhVlCYwrbgjYhfpbw7iShAlX3lbf1MJrJn4M3B7Bw1nsH-rEZBMvRzHI0szyaOeBvThv4CP-zLv0DWgnulg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2470513976</pqid></control><display><type>article</type><title>The Association of Serum Lipid Levels with Breast Cancer Risks Among Women with Breast Cancer at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Taylor &amp; Francis Open Access Journals</source><creator>Kumie, Getinet ; Melak, Tadele ; Wondifraw Baynes, Habtamu</creator><creatorcontrib>Kumie, Getinet ; Melak, Tadele ; Wondifraw Baynes, Habtamu</creatorcontrib><description>Breast cancer is a malignant condition affecting about 2.1 million women worldwide. Cancer cells have increased the level of cholesterol and facilitate lipid biosynthesis and metabolism. Therefore, there is a need for assessment of serum lipid and its association with breast cancer risks. A comparative cross-sectional study was conducted among women with breast cancer (n=23), benign breast lump (n=68) and apparently healthy control (n=91) at Felege Hiwot Comprehensive Specialized Hospital, from January to May, 2020. A convenient sampling technique and an interviewer-administered questionnaires were used to collect data. Five milliliter of fasting blood sample was collected for lipid level analysis using enzymatic colorimetric method. Data entry and analysis were done using Epi Info version 7 and SPSS version 20. One way ANOVA and logistic regression were the tools used for analysis, and a p-value of &lt;0.05 was considered as statistically significant. The mean age of healthy control, benign and malignant breast cancer was 32.51±9.44, 33.34±10.664 and 37.65±14.345 years, respectively. The mean serum value of TG among controls, benign and malignant women was 168.67±41.616, 170.1±59.018 and 211.7±82.924 (p&lt;0.001), respectively. The mean serum concentration of HDL-c was significantly different between the three groups (47.61±9.122, 44.69±14.479 and 38.26±7.442: p=0.004) among controls, benign and malignant, respectively. Low serum HDL-c level was significantly associated with age at parity (AOR=3.353; 95% CI=1.33, 8.436), the habit of drinking alcohol (AOR=2.125; 95% CI=1.065, 4.241) and BMI (AOR=3.555; 95% CI=1.13, 11.184). In addition, BMI (AOR: 4.54; 95% CI: 1.45, 14.21) was statistically associated with high LDL-c level. The overall prevalence of dyslipidemia was high in breast cancer patients. Age at first parity, alcohol consumption and BMI were significantly associated with low serum HDL-c level.</description><identifier>ISSN: 1179-1314</identifier><identifier>EISSN: 1179-1314</identifier><identifier>DOI: 10.2147/BCTT.S279291</identifier><identifier>PMID: 33363407</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Age ; Alcohol use ; Benign ; Blood pressure ; Breast cancer ; Breastfeeding &amp; lactation ; Cancer ; Cancer therapies ; Cholesterol ; Colorimetry ; Comparative analysis ; Drinking behavior ; Dyslipidemia ; Enzymes ; ethiopia ; Family medical history ; Health care ; High density lipoprotein ; Hypertension ; Lipid metabolism ; lipid profile ; Lipids ; Lipoproteins ; Low density lipoprotein ; Low density lipoproteins ; Menstruation ; Metabolic disorders ; Oncology, Experimental ; Original Research ; Patients ; Physiological aspects ; Risk factors ; Sociodemographics ; Statistical analysis ; Tumor necrosis factor-TNF ; women ; Womens health</subject><ispartof>Breast cancer targets and therapy, 2020-01, Vol.12, p.279-287</ispartof><rights>2020 Kumie et al.</rights><rights>COPYRIGHT 2020 Dove Medical Press Limited</rights><rights>2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Kumie et al. 2020 Kumie et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c576t-98ffe2ae58242b41940aa9daf149dd23058184f1de399b23f85a97f384019633</citedby><cites>FETCH-LOGICAL-c576t-98ffe2ae58242b41940aa9daf149dd23058184f1de399b23f85a97f384019633</cites><orcidid>0000-0003-1617-6249 ; 0000-0003-0650-0666</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2470513976/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2470513976?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33363407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kumie, Getinet</creatorcontrib><creatorcontrib>Melak, Tadele</creatorcontrib><creatorcontrib>Wondifraw Baynes, Habtamu</creatorcontrib><title>The Association of Serum Lipid Levels with Breast Cancer Risks Among Women with Breast Cancer at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia</title><title>Breast cancer targets and therapy</title><addtitle>Breast Cancer (Dove Med Press)</addtitle><description>Breast cancer is a malignant condition affecting about 2.1 million women worldwide. Cancer cells have increased the level of cholesterol and facilitate lipid biosynthesis and metabolism. Therefore, there is a need for assessment of serum lipid and its association with breast cancer risks. A comparative cross-sectional study was conducted among women with breast cancer (n=23), benign breast lump (n=68) and apparently healthy control (n=91) at Felege Hiwot Comprehensive Specialized Hospital, from January to May, 2020. A convenient sampling technique and an interviewer-administered questionnaires were used to collect data. Five milliliter of fasting blood sample was collected for lipid level analysis using enzymatic colorimetric method. Data entry and analysis were done using Epi Info version 7 and SPSS version 20. One way ANOVA and logistic regression were the tools used for analysis, and a p-value of &lt;0.05 was considered as statistically significant. The mean age of healthy control, benign and malignant breast cancer was 32.51±9.44, 33.34±10.664 and 37.65±14.345 years, respectively. The mean serum value of TG among controls, benign and malignant women was 168.67±41.616, 170.1±59.018 and 211.7±82.924 (p&lt;0.001), respectively. The mean serum concentration of HDL-c was significantly different between the three groups (47.61±9.122, 44.69±14.479 and 38.26±7.442: p=0.004) among controls, benign and malignant, respectively. Low serum HDL-c level was significantly associated with age at parity (AOR=3.353; 95% CI=1.33, 8.436), the habit of drinking alcohol (AOR=2.125; 95% CI=1.065, 4.241) and BMI (AOR=3.555; 95% CI=1.13, 11.184). In addition, BMI (AOR: 4.54; 95% CI: 1.45, 14.21) was statistically associated with high LDL-c level. The overall prevalence of dyslipidemia was high in breast cancer patients. Age at first parity, alcohol consumption and BMI were significantly associated with low serum HDL-c level.</description><subject>Age</subject><subject>Alcohol use</subject><subject>Benign</subject><subject>Blood pressure</subject><subject>Breast cancer</subject><subject>Breastfeeding &amp; lactation</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Cholesterol</subject><subject>Colorimetry</subject><subject>Comparative analysis</subject><subject>Drinking behavior</subject><subject>Dyslipidemia</subject><subject>Enzymes</subject><subject>ethiopia</subject><subject>Family medical history</subject><subject>Health care</subject><subject>High density lipoprotein</subject><subject>Hypertension</subject><subject>Lipid metabolism</subject><subject>lipid profile</subject><subject>Lipids</subject><subject>Lipoproteins</subject><subject>Low density lipoprotein</subject><subject>Low density lipoproteins</subject><subject>Menstruation</subject><subject>Metabolic disorders</subject><subject>Oncology, Experimental</subject><subject>Original Research</subject><subject>Patients</subject><subject>Physiological aspects</subject><subject>Risk factors</subject><subject>Sociodemographics</subject><subject>Statistical analysis</subject><subject>Tumor necrosis factor-TNF</subject><subject>women</subject><subject>Womens health</subject><issn>1179-1314</issn><issn>1179-1314</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptktFq2zAUhs3YWEvXu10PwWDsoskkS7asm0Ea2qUQNlgCuxSyfRQrsy1PshO259mDTl6ykoxKAomj7_wHHf1R9JrgaUwY_3A7X6-nq5iLWJBn0SUhXEwIJez5yfkiuvZ-i8fBMWP8ZXRBKU0pw_wy-r2uAM28t4VRvbEtshqtwA0NWprOlGgJO6g92pu-QrcOlO_RXLUFOPTV-O8ezRrbbtA320D7FKR6dA81bAAtzN6GsG06BxW03uwArToIZWvzC0q0sL4zvapv0Gfr-moPQeSur4ztjHoVvdCq9nB93K-i9f3der6YLL98epjPlpMi4Wk_EZnWECtIspjFOSOCYaVEqTRhoixjipOMZEyTEqgQeUx1lijBNc0YJiKl9Cp6OMiWVm1l50yj3E9plZF_A9ZtpHK9KWqQISsRRZ5ShRNWpjqHHOcgwiI44zkLWh8PWt2QN1AW0PZO1Wei5zetqeTG7iTnCc1EEgTeHwWc_TGEbsjG-ALqWrVgBy9jxsMPppinAX37H7q1g2tDp0YKJ4SKU2qjwgNMq22oW4yicpayLEmyFMeBmj5BhVlCYwrbgjYhfpbw7iShAlX3lbf1MJrJn4M3B7Bw1nsH-rEZBMvRzHI0szyaOeBvThv4CP-zLv0DWgnulg</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Kumie, Getinet</creator><creator>Melak, Tadele</creator><creator>Wondifraw Baynes, Habtamu</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-1617-6249</orcidid><orcidid>https://orcid.org/0000-0003-0650-0666</orcidid></search><sort><creationdate>20200101</creationdate><title>The Association of Serum Lipid Levels with Breast Cancer Risks Among Women with Breast Cancer at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia</title><author>Kumie, Getinet ; Melak, Tadele ; Wondifraw Baynes, Habtamu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c576t-98ffe2ae58242b41940aa9daf149dd23058184f1de399b23f85a97f384019633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>Alcohol use</topic><topic>Benign</topic><topic>Blood pressure</topic><topic>Breast cancer</topic><topic>Breastfeeding &amp; lactation</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Cholesterol</topic><topic>Colorimetry</topic><topic>Comparative analysis</topic><topic>Drinking behavior</topic><topic>Dyslipidemia</topic><topic>Enzymes</topic><topic>ethiopia</topic><topic>Family medical history</topic><topic>Health care</topic><topic>High density lipoprotein</topic><topic>Hypertension</topic><topic>Lipid metabolism</topic><topic>lipid profile</topic><topic>Lipids</topic><topic>Lipoproteins</topic><topic>Low density lipoprotein</topic><topic>Low density lipoproteins</topic><topic>Menstruation</topic><topic>Metabolic disorders</topic><topic>Oncology, Experimental</topic><topic>Original Research</topic><topic>Patients</topic><topic>Physiological aspects</topic><topic>Risk factors</topic><topic>Sociodemographics</topic><topic>Statistical analysis</topic><topic>Tumor necrosis factor-TNF</topic><topic>women</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumie, Getinet</creatorcontrib><creatorcontrib>Melak, Tadele</creatorcontrib><creatorcontrib>Wondifraw Baynes, Habtamu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Breast cancer targets and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumie, Getinet</au><au>Melak, Tadele</au><au>Wondifraw Baynes, Habtamu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Association of Serum Lipid Levels with Breast Cancer Risks Among Women with Breast Cancer at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia</atitle><jtitle>Breast cancer targets and therapy</jtitle><addtitle>Breast Cancer (Dove Med Press)</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>12</volume><spage>279</spage><epage>287</epage><pages>279-287</pages><issn>1179-1314</issn><eissn>1179-1314</eissn><abstract>Breast cancer is a malignant condition affecting about 2.1 million women worldwide. Cancer cells have increased the level of cholesterol and facilitate lipid biosynthesis and metabolism. Therefore, there is a need for assessment of serum lipid and its association with breast cancer risks. A comparative cross-sectional study was conducted among women with breast cancer (n=23), benign breast lump (n=68) and apparently healthy control (n=91) at Felege Hiwot Comprehensive Specialized Hospital, from January to May, 2020. A convenient sampling technique and an interviewer-administered questionnaires were used to collect data. Five milliliter of fasting blood sample was collected for lipid level analysis using enzymatic colorimetric method. Data entry and analysis were done using Epi Info version 7 and SPSS version 20. One way ANOVA and logistic regression were the tools used for analysis, and a p-value of &lt;0.05 was considered as statistically significant. The mean age of healthy control, benign and malignant breast cancer was 32.51±9.44, 33.34±10.664 and 37.65±14.345 years, respectively. The mean serum value of TG among controls, benign and malignant women was 168.67±41.616, 170.1±59.018 and 211.7±82.924 (p&lt;0.001), respectively. The mean serum concentration of HDL-c was significantly different between the three groups (47.61±9.122, 44.69±14.479 and 38.26±7.442: p=0.004) among controls, benign and malignant, respectively. Low serum HDL-c level was significantly associated with age at parity (AOR=3.353; 95% CI=1.33, 8.436), the habit of drinking alcohol (AOR=2.125; 95% CI=1.065, 4.241) and BMI (AOR=3.555; 95% CI=1.13, 11.184). In addition, BMI (AOR: 4.54; 95% CI: 1.45, 14.21) was statistically associated with high LDL-c level. The overall prevalence of dyslipidemia was high in breast cancer patients. Age at first parity, alcohol consumption and BMI were significantly associated with low serum HDL-c level.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>33363407</pmid><doi>10.2147/BCTT.S279291</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-1617-6249</orcidid><orcidid>https://orcid.org/0000-0003-0650-0666</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1179-1314
ispartof Breast cancer targets and therapy, 2020-01, Vol.12, p.279-287
issn 1179-1314
1179-1314
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_7f359cb63a054d6fbeb0be9be91087b4
source Open Access: PubMed Central; Publicly Available Content Database; Taylor & Francis Open Access Journals
subjects Age
Alcohol use
Benign
Blood pressure
Breast cancer
Breastfeeding & lactation
Cancer
Cancer therapies
Cholesterol
Colorimetry
Comparative analysis
Drinking behavior
Dyslipidemia
Enzymes
ethiopia
Family medical history
Health care
High density lipoprotein
Hypertension
Lipid metabolism
lipid profile
Lipids
Lipoproteins
Low density lipoprotein
Low density lipoproteins
Menstruation
Metabolic disorders
Oncology, Experimental
Original Research
Patients
Physiological aspects
Risk factors
Sociodemographics
Statistical analysis
Tumor necrosis factor-TNF
women
Womens health
title The Association of Serum Lipid Levels with Breast Cancer Risks Among Women with Breast Cancer at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T20%3A17%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Association%20of%20Serum%20Lipid%20Levels%20with%20Breast%20Cancer%20Risks%20Among%20Women%20with%20Breast%20Cancer%20at%20Felege%20Hiwot%20Comprehensive%20Specialized%20Hospital,%20Northwest%20Ethiopia&rft.jtitle=Breast%20cancer%20targets%20and%20therapy&rft.au=Kumie,%20Getinet&rft.date=2020-01-01&rft.volume=12&rft.spage=279&rft.epage=287&rft.pages=279-287&rft.issn=1179-1314&rft.eissn=1179-1314&rft_id=info:doi/10.2147/BCTT.S279291&rft_dat=%3Cgale_doaj_%3EA648558602%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c576t-98ffe2ae58242b41940aa9daf149dd23058184f1de399b23f85a97f384019633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2470513976&rft_id=info:pmid/33363407&rft_galeid=A648558602&rfr_iscdi=true